Goal: Investigate clinical efficacy of EVA System (enhanced VIA) for identification of lesions by histopathology ground truth.
Methods: Patients underwent VIA screening, followed by digital cervicography. If found positive, they were treated in a single visit approach to limit LTFU. However, confirmatory biopsies were taken for the study.
Outcome: 36 of 250 women screened with the EVA System had a positive visualization identification for dysplasia. Of the group with identified dysplasia, 28 women underwent biopsies, all of which confirmed the visual findings, and that the EVA System was also able to differentiate between high-grade (HGD) and low-grade dysplasia in all 28 women who had biopsies.